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Extracts of 16 South African Salvia species commonly used in traditional medicine to treat various microbial infections were investigated
for in vitro antibacterial and antimycobacterial activities using the micro-dilution and respiratory BACTEC method, respectively. The micro-
organisms tested include two Gram-positive (Staphylococcus aureus and Bacillus cereus); two Gram-negative (Escherichia coli and Kleb-
siella pneumoniae) bacterial strains and the common pathogen responsible for tuberculosis, Mycobacterium tuberculosis. Extracts of the
majority of species exhibited moderate to good antibacterial activity with minimum inhibitory concentration (MIC) values ranging from 0.03 to
8.00 mg/ml. Promising activity was observed against M. tuberculosis (MIC≤0.50 mg/ml) with S. radula, S. verbenaca and S. dolomitica
displaying the most favourable activity (MIC: 0.10 mg/ml). The antibacterial bioassay-guided fractionation of S. chamelaeagnea resulted in
the isolation of four compounds: carnosol, 7-O-methylepirosmanol, oleanolic acid and its isomer ursolic acid as the active principles against
S. aureus. The in vitro antibacterial and antimycobacterial activities may support the use of Salvia species in traditional medicine to treat
microbial infections.
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Despite the progress in understanding the growth and
control of many pathogens, nearly all the diseases affecting
millions of people (especially in developing countries) are
still caused by micro-organisms. Tuberculosis (TB), a
mycobacterial infection, remains a serious health problem in
many regions of the world. It is estimated that a third of the
world's population is infected with Mycobacterium tubercu-
losis and approximately 1.7 million people have died from TB
worldwide in 2003 (WHO, 2005). In 2004, TB killed half a
million people in Africa, mostly young men and women in
their most productive years. Africa is the only continent where
the TB rates are increasing. The current threat in TB treatment⁎ Corresponding author.
E-mail address: viljoenam@tut.ac.za (A.M. Viljoen).
0254-6299/$ - see front matter © 2007 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2007.05.001lies in the emergence of resistant strains (Mativandlela et al.,
2006). In the past years, the development of resistance by
pathogens to many of the commonly used antibiotics provides
sufficient impetus for further attempts to search for new
antimicrobial agents (Grange and Davey, 1990). Plant-derived
natural products may offer potential leads for novel com-
pounds and species of the genus Salvia (sage) are potential
candidates in this regard, since they have long been used as a
frequent component of herbal mixtures to treat tuberculo-
sis and a range of microbial infections (Watt and Breyer-
Brandwijk, 1962).
The genus Salvia belongs to the family Lamiaceae and
encompasses about 900 species worldwide of which 26 are
found in southern Africa (Jäger and Van Staden, 2000).
Members of the genus are extensively used in South Africa in
healing rites especially to treat infections. This work forms part
of a greater study to document the chemistry and biological
activity of South African medicinal aromatic plants.ts reserved.
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2.1. Plant material
The aerial parts of 16 Salvia species were collected at
various localities in South Africa between December 2003 and
December 2004, predominantly from the Cape region (Table 1).
Variation within and between populations were not taken into
account and only one representative per species was considered.
The identity of each species was confirmed by the South
African National Biodiversity Institute (Pretoria) and voucher
specimens were deposited in the School of Pharmacy, Tshwane
University of Technology, Pretoria, South Africa.
2.2. Chemicals, reagents and standards
Acetic acid, dioxane and DMSO were obtained from
Saarchem; analytical grade of acetone, chloroform, dichlor-
omethane, ethyl acetate, hexane, methanol and toluene were
from Rochelle Chemicals; Tryptone Soya agar (TSA) and
Tryptone Soya broth (TSB) were purchased from CA Milsch;
ciprofloxacin was obtained from Merck and p-iodonitrotetra-
zolium chloride (INT), ursolic acid (042k1240) and oleanolic
acid (093k0961) were from Sigma. The BACTEC™ 12B
medium and rifampicin were obtained from Becton Dickinson.
Column chromatography was carried out on glass columns with
silica gel 60, 70–230 mesh ASTM. Thin-layer chromatography
(TLC) was done on pre-coated silica gel 60 F254 plates
(0.25 mm, Macherey-Nagel).Table 1












S. africana-caerulea AV 875 4.00 4.67
S. africana-lutea AV 873 3.00 3.00
S. albicaulis AV 894 4.00 4.67
S. aurita AV 1066 4.00 4.00
S. chamelaeagnea AV 848 1.00 3.00
S. disermas AV 1194 4.00 2.00
S. dolomitica AV 838 3.33 2.00
S. garipensis AV 1193 1.88 2.81
S. lanceolata AV 877 4.00 2.00
S. muirii AV 874 2.00 3.00
S. radula AV 880 N16.00 4.00
S. repens AV 615 2.00 3.00
S. runcinata AV 679 2.00 4.00
S. schlechteri AV 1068 4.00 3.00
S. stenophylla AV 893 4.00 2.00
S. verbenaca AV 631 8.00 2.00
Carnosol 2.00 2.00
Oleanolic acid 3.41 1.71
Ursolic acid 2.50 3.75 7.3
7-O-Methyl-epirosmanol nd nd
Controls 4.00×10−5a 1.60×10−4a 4.10
KBG: Kirstenbosch Botanical Garden, S: sensitive; R: resistant.ΔGI value of the con
active againstM. tuberculosis, ΔGI must be less than the ΔGI of the control vial. aAn
ml) was included in each run. nd: not determined due to insufficient amount of the2.3. Plant extraction
Aerial parts of each plant were air-dried at room temperature
and the finely ground powder extracted three timeswithmethanol:
chloroform (1:1, v/v) in a 36–40 °C water bath for 3 h. The
suspension was filtered through Whatman® No 1 filter paper and
the filtrate was concentrated to dryness under reduced pressure.
2.4. Determination of the antibacterial and antimycobacterial
activities
The in vitro antibacterial activity was evaluated by the
micro-dilution assay (Eloff, 1998) against two Gram-positive
organisms Bacillus cereus (ATCC 11778) and Staphylococcus
aureus (ATCC 25923); and, two Gram-negative organisms
Klebsiella pneumoniae (NTCC 9633) and Escherichia coli
(ATCC 8739). Briefly, the stock solution (64 mg/ml in acetone)
was serially diluted (1:1) with sterile water in a 96-well
microtitre plate before an equal volume (100 μl) of bacterial
suspension yielding approximately an inoculum size of
1×106 CFU/ml added to the wells and the plate incubated for
24 h. Thereafter, 0.04% (w/v) INT was added to each well and
the plate left at room temperature for 6 h before the results were
recorded. Sterile broth containing bacterial suspension was used
to observe the normal growth, while ciprofloxacin was used as
positive antibacterial control.
The susceptibility of M. tuberculosis H37Ra (ATCC 25177)
to the plant extracts was assayed using the radiometric
technique (Siddiqi et al., 1981). The mycobacterial suspensiont various pathogens










6.00 3.00 0 (S) −3 (S) 73 (R) 0.50
0.75 0.75 0 (S) 0 (S) 50 (R) 0.50
1.00 1.00 0 (S) 0 (S) 41 (R) 0.50
0.25 0.05 0 (S) 4 (S) 33 (R) 0.50
0.03 0.06 0 (S) 1 (S) 37 (R) 0.50
3.00 0.75 0 (S) 18 (S) 520 (R) 0.50
0.75 0.03 2 (S) −1 (S) 11 (S) 0.10
0.75 4.00 nd nd nd nd
3.00 2.00 0 (S) −1 (S) 40 (R) 0.50
0.25 0.36 0 (S) 7 (S) 33 (R) 0.50
1.00 0.06 −1 (S) 4 (S) 10 (S) 0.10
0.03 0.25 0 (S) 2 (S) 48 (R) 0.50
0.03 0.25 0 (S) 4 (S) 40 (R) 0.50
0.75 0.25 0 (S) 19 (S) 38 (R) 0.50
0.03 0.06 0 (S) 8 (S) 38 (R) 0.50
2.00 3.00 −2 (S) 3 (S) 5 (S) 0.10
0.02 0.03 – – – –
1.28 3.75 – – – –
2×10−3 0.01 – – – –
0.01 0.02 – – – –
×10−5a 3.10×10−4a 0 (S)b 0 (S)b 0 (S)b b2.00×10−3b
trol vial 29, 29 and 28 for 1, 0.5 and 0.1 mg/ml, respectively. For the sample to be
tibacterial control ciprofloxacin, banti-tuberculosis rifampicin control vial (2 μg/
sample.
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turbidity standard (Lall and Meyer, 1999). A 12B vial was then
inoculated with 100 μl of the mycobacterial suspension and
incubated at 37 °C until the growth reached 400–500. The
suspended culture was used undiluted to inoculate a set of
12B vials, 100 μl per vial yielding approximately 1×104–1×
105 CFU/ml (Heifets et al., 1985) before the filtered stock
solution of plant extract (100 μl, 42 mg/ml in 50% methanol)
was added to the vials to obtain final concentrations of 1, 0.5
and 0.1 mg/ml. The control vial was inoculated with a 1:100
dilution of the culture and the vials were incubated at 37 °C and
monitored on a daily basis. Rifampicin, a standard antitubercu-
losis drug, was used as a positive control at a final concentration
of 2 μg/ml.
The lowest concentration of the test sample in which no
growth occurred was defined as the minimum inhibitory con-
centration (MIC). To evaluate the antimycobacterial activity, the
difference in the growth index (GI) values of the last two days
was designated asΔGI and the results were interpreted once the
control vial reached a GI value 30. The following formula was
used to interpret the results: ΔGI controlNΔGI extract= resis-
tant; ΔGI controlbΔGI extract=susceptible and the MIC was
determined as the lowest concentration of drug inhibiting more
than 99% of the mycobacterial population. For each analysis,
the treatment was performed singularly and at least three ex-
periments were carried out.
2.5. Isolation and identification of antibacterial compounds
from S. chamelaeagnea
To determine the compounds responsible for the antibacterial
activity, S. chamelaeagnea was selected as it showed good
activity. Briefly, dried aerial parts (423.4 g) were powdered,
extracted with methanol:chloroform (1:1 ratio, v/v) and
evaporated under reduced pressure to yield 19.6 g. The residue
was subjected to column chromatography with silica gel 60
using hexane:dichloromethane (9:1), dichloromethane:metha-
nol (6:1) and 100% methanol consecutively as eluent. Spots on
TLC plates were visualized under UV light and sprayed with
anisaldehyde–H2SO4 reagent followed by heating at 100 °C for
5 min and fractions showing similar chromatograms were
combined to yield five main fractions. To identify the active
principles, a direct antibacterial bio-assay (Dilaka and Meyer,
1996) on a TLC plate was employed using the agar-overlay
method with S. aureus as the test organism. Each of the five
fractions (1–5) collected was spotted on a TLC plate. The dried
TLC plate was then sterilized under UV light (254 nm) for 1 h
before being placed in a petri dish containing the solidified agar.
The UV light was used to sterilize the dried extract instead of
autoclaving in order to avoid destruction of the potency of the
active constituents by heat (Okoli and Iroegbu, 2004). The plate
was then sprayed with S. aureus culture in Tryptone Soya agar
and left to solidify. After 1 h in the fridge (to allow compounds
on the TLC to diffuse normally), the plate was removed and
incubated at 37 °C. At the end of the overnight incubation, it
was sprayed with a 0.04% aqueous solution of INT to visualize
the inhibition zone. The inhibition zone was indicated by theclear zone on the red background. Only fraction 4 exhibited
activity and was selected for further analysis. It was evaporated
under vacuum to yield 6.21 g. This fraction was rechromato-
graphed in a small column (2.5 cm×45 cm) using hexane:ethyl
acetate:acetic acid (12:3:0.02) as an eluent. A total of 322 sub-
fractions in 3 ml test tubes were collected and compound 1
(120 mg) was obtained as white crystals. Similar fractions were
then combined and subjected to a bio-autographic assay on a
TLC plate to detect a fraction containing other active compound
(s). The eluted fraction was monitored on a TLC plate
developed with the same solvent system. Pooled fractions
were concentrated with a rotary evaporator and rechromato-
graphed using the same column with hexane:ethyl acetate:acetic
acid (12:2:0.01) as the solvent system. The combined fractions
yielded seven subfractions and only subfractions 2 and 4
showed activity. Subfraction 2, eluted with hexane:ethyl
acetate:acetic acid (12:3:0.01) and toluene:ethyl acetate (12:3)
successively after repeated column chromatography yielded
compound 2 (12 mg). Compounds 3 and 4 (7 mg) were obtained
as an inseparable mixture after repeated column chromatogra-
phy of subfraction 4 with hexane:ethyl acetate:acetic acid
(12:3:0.01) followed by toluene:ethyl acetate (12:3). The
isolated compounds were structurally characterized using 1H
and 13C, nuclear magnetic resonance spectroscopy (NMR),
mass spectrometry (MS) on the GC-MS QP 2010 gas
chromatography mass spectrometer and the structures com-
pared to those found in literature [1 and 2 (Urones et al., 1998),
3 and 4 (Mahato and Kundu, 1994)].
3. Results and discussion
3.1. Antibacterial and antimycobacterial activities
The results of the antibacterial activity showed that the
methanol: chloroform (1:1) extracts exhibited good to moderate
antibacterial activity with MIC values ranging between 0.03 to
8.00 mg/ml (Table 1). Only S. radula failed to inhibit the
growth of E. coli but showed significant activity against the
other pathogens. The most promising activity was obtained with
S. chamelaeagnea.
The results for the antimycobacterial activity were interpreted
after two weeks when the control vial containing 1:100 dilution
of the inoculum reached a ΔGI value of approximately 30. The
ΔGI results and the MIC values of the species examined are
listed in Table 1. TheM. tuberculosiswas sensitive to all extracts
and therefore exhibited potent antimycobacterial activity. Of the
species tested, 11 have MIC values of 0.50 mg/ml, while the
MIC values of three species are 0.10 mg/ml. It was noted that
species such as S. verbenaca, S. radula and S. dolomitica which
displayed good antimycobacterial activity (MIC: 0.10 mg/ml)
also exhibited good antibacterial activity. According to Fabry
et al. (1998), the solvent extracts of plants with MIC values less
than 8 mg/ml may be considered as antimicrobially active. The
values obtained in this study were less than 8.0 mg/ml against all
the pathogens tested. These results are consistent with the pattern
for the in vitro activity emerging from published works. In our
previous investigation (Kamatou et al., 2005), we found that
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against a range of pathogens. The antibacterial activity of exotic
Salvia species has also been reported in the literature (Lee et al.,
1999; Ulubelen et al., 2001; Tepe et al., 2004). Salvia species are
rich in phenolic compounds which are known to display a broad
range of biological activities such as antibacterial, anti-oxidant,
anticancer and anti-inflammatory activities (Lu and Foo, 2001).
Infections caused by S. aureus are among the most difficult to
treat with standard clinical antibacterial agents (Tomás-Barberán
et al., 1990). The growth of S. aureus was inhibited by all
extracts (Table 1) especially by S. radula, S. chamelaeagnea,
S. aurita and S. dolomitica (MIC≤0.06 mg/ml). Thus, these
plants could yield compounds that may improve the treatment of
infections caused by S. aureus in particular. It was reported that
many species of Salvia are used in decoctions in South Africa by
Sotho people against various bacterial infections such as throat
inflammation, colds and coughs and to treat pulmonary diseases
such as tuberculosis (Watt and Breyer-Brandwijk, 1962). The
positive in vitro results indicate that Salvia species may be used
to combat microbial infections.
3.2. Elucidation and identification of the isolated compound
from S. chamelaeagnea
The methanol:chloroform extract which exhibited the best
antibacterial activity was subjected to column chromatography,
isolation and purification to yield four known compounds. The
compounds were identified by analysis of their NMR and MS
data and comparison with data reported in the literature. Com-
pound 1, isolated as white crystals, was a diterpene characterized
as carnosol. Compound 2, also a diterpene, was isolated as a
white powder and characterized as 7-O-methylepirosmanol.
Compounds 3 and 4 were isolated as an inseparable mixture ofFig. 1. Chemical structures oftriterpenes identified as (3β)-3-hydroxyurs-12-en-28-oic acid,
commonly known as ursolic acid (C30H48O3), and its isomer
(3β)-3-hydroxyolean-12-en-28-oic acid, generally known as
oleanolic acid. The structures of the isolated compounds are
presented in Fig. 1. The antibacterial MIC values of the isolated
compounds were also determined (Table 1). Ursolic acid ex-
hibited the most favourable activity among the isolated com-
pounds. It was noted that this compound was 175 times more
active than its isomer oleanolic acid against Gram-positive
bacteria.
The isolated compounds exhibited some degree of activity
against S. aureus and to a lesser degree against B. cereus, while
no clear pattern was obtained between the isolated compounds
and the crude extract against other pathogens. The solvent
extracts are crude preparations and it was expected that the
isolated compounds would display higher antibacterial activity
than the crude extract, as it would be present in a higher
concentration. However, this was not the case particularly for
oleanolic acid and may partly be attributed to the liability of the
isolated compounds. Furthermore, it is not possible to quantify
the antibacterial activity from a bio-autographic assay where the
inhibition spot is by nature a positive/negative response and
does not reveal detail about the degree of activity of a
compound. The mechanism of many phytomedicines is still
unknown and there are several instances where the total herb
extract exhibits a better effect than an equivalent dose of an
isolated compound. The anti-inflammatory activity of ginkgo-
lides isolated from Ginko biloba was less effective than the
plant extract (Williamson, 2001). Horiuchi et al. (2007) also
found that a crude extract from Salvia officinalis reduced the
MICs of aminoglycosides in vancomycin-resistant enterococci,
while the effective compound from the extract (carnosol)
showed weak antimicrobial activity. However, the effect ofthe isolated compounds.
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Oluwatuyi et al. (2004) also found that incorporation of
carnosol and carnosic acid into the growth medium caused a
32- and 16-fold potentiation of the activity of erythromycin
against an erythromycin effluxing strain S. aureus. Since four
compounds were isolated, it is possible that they may also act
synergistically to give the overall antibacterial activity obtained
with the crude extract.
Carnosol has previously been reported to displayed antibac-
terial activity against various micro-organisms including
S. aureus, B. subtilis, E. coli and C. albicans (Collins and
Charles, 1987; Dimayuga et al., 1991; Oluwatuyi et al., 2004). It
is a compound present in many Salvia species and was first
isolated from S. carnosa (Dougl.) (White and Jenkins, 1942).
Since then, this compound has been detected in Rosmarinus
officinalis and many other species belonging to the Lamiaceae
(Wu et al., 1982). A mixture of ursolic acid and its isomer
oleanolic acid was isolated previously from Swertia arisanensis
(Gentianaceae) (Lin et al., 1987) and the two compounds have
been found in more than 120 plant species including the
Lamiaceae. Contemporary scientific research which led to the
isolation and identification of ursolic acid revealed and confirmed
that several pharmacological effects, such as antitumour,
hepatoprotective, anti-inflammatory, anti-ulcer, antimicrobial,
antihyperlipidemic and antiviral activity can be attributed to
ursolic acid (Liu, 1995). Ursolic acid/oleanolic acid and
derivatives from the Lamiaceae exhibited antimicrobial activity
and these therapeutic effects have been confirmed by laboratory
testing (Sattar et al., 1995). Ursolic acid was also identified as one
of the active principles in Rosmarinus officinalis (Lamiaceae) to
inhibit the growth of some food borne pathogens (Collins and
Charles, 1987).
The potency of natural substances could provide a scientific
basis for some of the health benefits claimed for indigenous
sages in folk medicine and warrant further studies to assess their
potential as effective natural remedies. The bioassay-guided
fractionation revealed four compounds responsible for the
antibacterial activity from S. chamelaeagnea, however, further
investigation is required in order to determine the compounds
responsible for the antimycobacterial activity from the most
active species and to evaluate the activity of isolated compounds
in combination. Carnosol and ursolic acid inhibit the growth of
food spoilage microbes. As carnosol is known to possess good
anti-oxidant activity, this compound may prove a useful sub-
stitute for some of the phenolic anti-oxidants in current use,
while offering an improved inhibitory capacity to microbial
growth. Most of the phytomedicines are on the drug market as
whole extracts of plants and traditional practitioners have always
believed that the collective action of many compounds present in
a plant is a vital part of the therapeutic efficacy.
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